Clearmind Medicine reported cash from operations of -$0.00B and free cash flow of -$0.00B for the quarter ended Apr 2026, down 61.0% year over year. This cash flow statement covers 17 quarters of results from Jan 2022 through Apr 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Jan2022 | Jul2022 | Oct2022 | Jan2023 | Apr2023 | Jul2023 | Oct2023 | Jan2024 | Apr2024 | Jul2024 | Oct2024 | Jan2025 | Apr2025 | Jul2025 | Oct2025 | Jan2026 | Apr2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||
| Net Income | 0.00B | -0.01B | 0.01B | 0.00B | -0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B |
| Share-based CompensationStock Comp. | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B |
| Deferred Taxes | 0.00B | 0.00B | -0.00B | 0.00B | 0.00B | -0.00B | -0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | |||||
| Gains from Investment SecuritiesGains Investment | 0.00B | -0.00B | 0.00B | -0.00B | -0.00B | 0.00B | -0.00B | -0.00B | -0.00B | 0.00B | 0.00B | 0.00B | -0.00B | -0.00B | |||
| Cash from OperationsCash from Ops. | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B |
| Depreciation, Depletion & Amortization | |||||||||||||||||
| Amortizatization of IntangiblesAmort. of Intangibles | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | -0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B |
| Depreciation & Amortization (CF)Dep. & Amort. | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | |||
| Change in Working Capital | |||||||||||||||||
| Change in ReceivablesChange Receivables | 0.00B | 0.00B | -0.00B | -0.00B | 0.00B | -0.00B | -0.00B | 0.00B | -0.00B | -0.00B | 0.00B | -0.00B | 0.00B | 0.00B | 0.00B | -0.00B | -0.00B |
| Change in Account PayablesChange Payables | -0.00B | 0.00B | 0.00B | -0.00B | 0.00B | -0.00B | 0.00B | -0.00B | -0.00B | -0.00B | 0.00B | 0.00B | -0.00B | 0.00B | 0.00B | 0.00B | -0.00B |
| Investing Activities | |||||||||||||||||
| Change in Acquisitions & DivestmentsChange Acquisitions | 0.00B | -0.00B | 0.00B | 0.00B | -0.00B | ||||||||||||
| Cash from Investing ActivitiesCash from Investing | -0.00B | 0.00B | -0.00B | 0.00B | -0.00B | 0.00B | -0.00B | ||||||||||
| Financing Activities | |||||||||||||||||
| Other financing activitiesOther financing | -0.00B | 0.00B | 0.00B | -0.00B | -0.00B | 0.00B | 0.00B | ||||||||||
| Cash from Financing ActivitiesCash from Financing | -0.00B | -0.00B | 0.01B | 0.00B | -0.00B | 0.00B | 0.01B | 0.00B | 0.00B | 0.00B | 0.00B | -0.00B | -0.00B | 0.00B | 0.01B | 0.00B | |
| Change in Capital Stock | |||||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | -0.00B | 1.00 | 0.01B | 0.00B | -0.00B | 0.00B | 0.00B | -0.00B | 0.00B | 0.01B | |||||||
| Dividend Payments | |||||||||||||||||
| Dividends Paid - CommonDiv. Paid (Common) | 0.00B | -0.00B | |||||||||||||||
| Additional items | |||||||||||||||||
| Exchange Rate EffectFX Effect | -319.19 | 142.00 | -0.00B | -0.00B | 0.00B | 0.00B | -0.00B | 0.00B | -0.00B | -0.00B | -0.00B | -0.00B | 20.00 | 0.00B | -861.00 | 0.00B | -0.00B |
| Change in Cash | -0.00B | -0.00B | -0.00B | 0.00B | 0.00B | -0.00B | 0.00B | 0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | 0.00B | 0.01B | 0.00B |
| Beginning Cash Balance | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.00B | 0.00B | ||||
| Free Cash FlowFCF | -0.00B | -0.00B | -0.00B | -3053.08B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B |
| Net Cash FlowNCF | -0.00B | -0.00B | -0.00B | -3053.07B | 0.00B | -0.00B | 0.00B | 0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | 0.00B | 0.01B | 0.00B |